Impending Net Drug Price Transparency Regulatio...

By Rene Pretorius

June 27, 2025

A new CMS rule to force drug price transparency is poised to reshape the pharmaceutical and healthcare landscape. With regulat...
Transparency in Industry Partnerships: Building Trust
Canada Launches Consultation for Essential Prescription Drugs List
RFK Jr.’s ACIP Overhaul: Examining Vaccine Policy Implications
Quantifying EU Medicine Access Challenges
US Argentina WHO Withdrawal: A Shift in Global Health Governance
EU Patent Licensing Framework: Enhancing Crisis Management in the EU
South Africa Health Reform: A Critical Examination of Universal Coverage Prop...
EU Establishes Expert Panel for Orphan Paediatric Devices
The Impact of MFN Pricing on the U.S. Biosimilar Market
Biosimilars Price Competition: Impact on U.S. Pharmaceutical Pricing and Mark...
MFN Drug Pricing Targets: Lowering U.S. Drug Costs Through International Alig...
A System Dynamics Approach to Lowering Drug Prices by 30–80% in the US